STERIS plc (STE)
Cash ratio
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 171,701 | 207,020 | 208,357 | 348,320 | 220,531 |
| Short-term investments | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 1,022,170 | 931,127 | 861,844 | 922,222 | 577,920 |
| Cash ratio | 0.17 | 0.22 | 0.24 | 0.38 | 0.38 |
March 31, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($171,701K
+ $—K)
÷ $1,022,170K
= 0.17
The cash ratio of STERIS plc has been fairly consistent over the years, ranging from 0.22 to 0.38. The cash ratio measures a company's ability to cover its short-term liabilities with its cash and cash equivalents. A higher cash ratio indicates a stronger ability to meet short-term obligations.
STERIS plc's cash ratio decreased from 0.38 in March 2021 to 0.24 in March 2023, indicating a potential decrease in its ability to cover short-term obligations with cash and cash equivalents. This could be a cause for concern as it may signal a decrease in liquidity or an increase in short-term liabilities.
However, it's worth noting that the cash ratio remained at 0.22 in March 2024, suggesting that STERIS plc may have taken steps to improve its liquidity position or manage its short-term obligations more effectively.
The absence of data for March 31, 2025, makes it difficult to provide a complete analysis for that period. Investors and stakeholders should continue to monitor STERIS plc's cash ratio over time to assess its financial health and liquidity position.
Peer comparison
Mar 31, 2025